- Home
- SOPH vs SRV Comparison
SOPH vs SRV Comparison
Compare SOPH & SRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOPH
- SRV
- Stock Information
- Founded
- SOPH 2011
- SRV 2007
- Country
- SOPH Switzerland
- SRV United States
- Employees
- SOPH N/A
- SRV N/A
- Industry
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- SRV Finance Companies
- Sector
- SOPH Health Care
- SRV Finance
- Exchange
- SOPH Nasdaq
- SRV Nasdaq
- Market Cap
- SOPH 193.8M
- SRV 176.7M
- IPO Year
- SOPH 2021
- SRV N/A
- Fundamental
- Price
- SOPH $3.29
- SRV $42.01
- Analyst Decision
- SOPH Strong Buy
- SRV
- Analyst Count
- SOPH 2
- SRV 0
- Target Price
- SOPH $6.50
- SRV N/A
- AVG Volume (30 Days)
- SOPH 168.1K
- SRV 33.9K
- Earning Date
- SOPH 08-05-2025
- SRV 01-01-0001
- Dividend Yield
- SOPH N/A
- SRV 13.38%
- EPS Growth
- SOPH N/A
- SRV N/A
- EPS
- SOPH N/A
- SRV N/A
- Revenue
- SOPH $67,173,000.00
- SRV N/A
- Revenue This Year
- SOPH $16.07
- SRV N/A
- Revenue Next Year
- SOPH $22.94
- SRV N/A
- P/E Ratio
- SOPH N/A
- SRV N/A
- Revenue Growth
- SOPH 4.66
- SRV N/A
- 52 Week Low
- SOPH $2.58
- SRV $30.73
- 52 Week High
- SOPH $4.92
- SRV $44.30
- Technical
- Relative Strength Index (RSI)
- SOPH 64.15
- SRV 55.97
- Support Level
- SOPH $2.99
- SRV $40.67
- Resistance Level
- SOPH $3.25
- SRV $42.43
- Average True Range (ATR)
- SOPH 0.23
- SRV 0.65
- MACD
- SOPH 0.03
- SRV -0.05
- Stochastic Oscillator
- SOPH 90.91
- SRV 63.57
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
About SRV NXG Cushing Midstream Energy Fund of Beneficial Interest
NXG Cushing Midstream Energy Fund is a non-diversified, closed-end management investment company with an investment objective of seeking a high after-tax total return from a combination of capital appreciation and current income. The fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in midstream energy investments.